C3 Global Biosciences

Las Vegas, United States Founded: 2016 • Age: 10 yrs Acquired By Isodiol
Cannabis-based wellness products are offered for health enhancement.

About C3 Global Biosciences

C3 Global Biosciences is a Healthcare company based in Las Vegas (United States) founded in 2016, and was acquired by Isodiol in December 2017. Cannabis-based wellness products are offered for health enhancement. C3 Global Biosciences offers products and services including exogen Capsules, exogen Tinctures, and exogen Topicals. Its focus areas include HealthTech, Cannabis HealthTech and Nutraceuticals. Its legal entity is C3 Global Biosciences, Inc. Its competitors include Vireo Health, Demetrix and Shopbeam; 1 of its 3 listed competitors has raised funding.

Company details

The company was founded in 2016 and is headquartered in Las Vegas, United States. Operations focus on the cannabis wellness sector, where CBD capsules, tinctures, and roll-on applicators are developed and distributed. These products are designed to address pain reduction, sleep disorders, stress, depression, and overall homeostasis. Distribution occurs through online and retail channels within the U.S. market.

  • Headquarters Las Vegas, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website c3globalbiosciences.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by Isodiol (Dec 2017)
  • Legal Name C3 Global Biosciences, Inc.
Key Metrics

Products & Services of C3 Global Biosciences

C3 Global Biosciences offers a comprehensive portfolio of products and services, including exogen Capsules, exogen Tinctures, and exogen Topicals.

exogen Capsules
Therapeutic Supplements

CBD capsules for health support and wellness enhancement.

exogen Tinctures
Therapeutic Supplements

Liquid CBD tinctures for targeted therapeutic applications.

exogen Topicals
Therapeutic Supplements

CBD topicals for external application in pain relief.

Investors in C3 Global Biosciences

C3 Global Biosciences has secured backing from 1 investor. Prominent investors backing the company include Isodiol.

All
InvestorDescriptionFounded YearDomainLocation
Cannabis products are manufactured and marketed by Isodiol International.
2014isodiol.comWatford, United Kingdom
Premium access

Investor details for C3 Global Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of C3 Global Biosciences

2 dated milestones of C3 Global Biosciences across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded C3 Global Biosciences is founded.
  2. Exit Acquired by Isodiol.

Competitors of C3 Global Biosciences

C3 Global Biosciences has 3 listed competitors in our database, 1 of them funded. They include Vireo Health, Demetrix and Shopbeam.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vireohealth.com2004Minneapolis, United States
Cannabis plants are cultivated in greenhouses for wellness product development.
demetrix.com2017Berkeley, United States$61M77
Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology.
shopbeam.com2018Boston, United States16
Provider of fine art photography prints and books
Premium access

Detailed competitors of C3 Global Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Cannabis Health Tech Ecosystem

3 companies that operate in the same segment as C3 Global Biosciences (Cannabis Health Tech Ecosystem) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Online marketplace platform for cannabis traders
2015New York, New York, United StatesUSD 195.4 M
Loyalty and marketing solutions for cannabis dispensaries are provided.
2012West Palm Beach, Florida, United StatesUSD 25.79 MUSD 22.83 M
An online marketplace for cannabis products is operated.
2017Bend, Oregon, United StatesUSD 603 M469
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about C3 Global Biosciences

C3 Global Biosciences was founded in 2016.

C3 Global Biosciences is headquartered in Las Vegas, United States. It is registered at Las Vegas, Nevada, United States.

The company was founded in 2016 and is headquartered in Las Vegas, United States. Operations focus on the cannabis wellness sector, where CBD capsules, tinctures, and roll-on applicators are developed and distributed. These products are designed to address pain reduction, sleep disorders, stress, depression, and overall homeostasis. Distribution occurs through online and retail channels within the U.S. market.

C3 Global Biosciences's top competitors include Vireo Health, Demetrix and Shopbeam.

C3 Global Biosciences offers exogen Capsules, exogen Tinctures, and exogen Topicals.

C3 Global Biosciences has 1 investor. Key investors include Isodiol.

C3 Global Biosciences operates through C3 Global Biosciences, Inc..

Yes. C3 Global Biosciences was acquired by Isodiol in December 2017.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available